Mitchell WA, Pink RC, Aspinall R. Biology of immune responses to vaccines in elderly persons. Vaccines in practice 2008; 1.2: 6

Vaccines in practice

Reference list

Mitchell WA, Pink RC, Aspinall R. Biology of immune responses to vaccines in elderly persons. Vaccines in practice 2008; 1.2: 6–8.

1. Nash D, Mostashari F, Fine A et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med, 2001; 344: 1807–1814.

2. O'Leary DR, Marfin AA, Montgomery SP et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4: 61–70.

3. Malaguarnera L, Ferlito L, Imbesi RM, Gulizia GS, Di Mauro S, Maugeri D et al. Immunosenescence: a review. Arch of Gerontol and Geriatr 2001; 32: 1–14.

4. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999; 108: 1–7.

5. http://www.cdc.gov/nchs/data/hus/hus05.pdf (last accessed 21 October 2008)

6. Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci USA. 2007; 104: 5692–5697.

7. Bauch CT, Galvani AP, Earn DJ. Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci U S A 2003; 100: 10564–10567.

8. Reluga TC, Bauch CT, Galvani AP. Evolving public perceptions and stability in vaccine uptake. Math Biosci 2006; 204: 185–198.

9. http://www.healthypeople.gov/Document/tableofcontents.htm#under (last accessed 21 October 2008)

10. http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles/immunisation (last accessed 21 October 2008)

11. Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations--United States, 1996. MMWR Morb Mortal Wkly Rep 1999. 48: 886–890.

12. Centers for Disease Control and Prevention (CDC). Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991-2002. MMWR Morb Mortal Wkly Rep 2004; 53: 1012–1015.

13. Reichert TA, Sugaya N, Fedson DS et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001. 344: 889–896.

14. Cohen J. Vaccine policy. Immunizing kids against flu may prevent deaths among the elderly. Science 2004; 306: 1123.

15. Longini IM, Halloran ME, Nizam A et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 2000; 18: 1902–1909.

16. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24: 1159–1169.

17. Galvani AP, Medlock J, Chapman GB. The ethics of influenza vaccination. Science 2006; 313: 758–760; author reply 758–760.

18. Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54: 893–897.

19. http://www.advisorybodies.doh.gov.uk/JCVI/mins-pneumococcal-220108.htm (last accessed 21 October 2008)

20. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002; 37: 455–463.

21. Aspinall R, Pido-Lopez J, Imami N et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res 2007; 10: 5–17.

22. Henson SM, Snelgrove R, Hussell T, Wells DJ, Aspinall R. J Immunol, 2005; 175: 4112–4118.

Published by Hayward Medical Communications